In conclusion, momordica charantia MAP30 can significantly inhibit the proliferation and migration of bladder cancer cells by downregulating the expression of CENPA and can promote cell apoptosis and cancer cellular senescence, thus playing a role in the treatment of bladder cancer. The gene discussed is CENPA; the disease is urinary bladder cancer.